Yaron Werber
Stock Analyst at TD Cowen
(1.65)
# 3,481
Out of 5,143 analysts
45
Total ratings
38.71%
Success rate
-0.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPT RAPT Therapeutics | Downgrades: Hold | n/a | $57.61 | - | 2 | Jan 20, 2026 | |
| VOR Vor Biopharma | Initiates: Buy | n/a | $18.08 | - | 1 | Dec 17, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $86 → $75 | $22.75 | +229.67% | 3 | Nov 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $44 → $51 | $44.81 | +13.81% | 3 | Nov 5, 2025 | |
| ARGX argenx SE | Maintains: Buy | $800 → $1,146 | $816.37 | +40.38% | 4 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $59 → $99 | $79.44 | +24.62% | 2 | Oct 30, 2025 | |
| ALEC Alector | Downgrades: Hold | n/a | $1.92 | - | 1 | Oct 22, 2025 | |
| IOBT IO Biotech | Downgrades: Hold | n/a | $0.21 | - | 2 | Sep 30, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $341.64 | -2.24% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $31.47 | - | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $48.03 | - | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $26.38 | - | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $153 | $216.66 | -29.38% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $132 → $122 | $118.00 | +3.39% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $31.59 | - | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $67 | $20.76 | +222.74% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $29.50 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.52 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.85 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $26.17 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.46 | - | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.08 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $32.95 | +15.33% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $22.98 | - | 1 | Oct 26, 2021 |
RAPT Therapeutics
Jan 20, 2026
Downgrades: Hold
Price Target: n/a
Current: $57.61
Upside: -
Vor Biopharma
Dec 17, 2025
Initiates: Buy
Price Target: n/a
Current: $18.08
Upside: -
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $86 → $75
Current: $22.75
Upside: +229.67%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $44.81
Upside: +13.81%
argenx SE
Oct 31, 2025
Maintains: Buy
Price Target: $800 → $1,146
Current: $816.37
Upside: +40.38%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $59 → $99
Current: $79.44
Upside: +24.62%
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.92
Upside: -
IO Biotech
Sep 30, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.21
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $341.64
Upside: -2.24%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $31.47
Upside: -
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $48.03
Upside: -
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $26.38
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $216.66
Upside: -29.38%
Nov 6, 2024
Maintains: Hold
Price Target: $132 → $122
Current: $118.00
Upside: +3.39%
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $31.59
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $71 → $67
Current: $20.76
Upside: +222.74%
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $29.50
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.52
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $4.85
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $26.17
Upside: -
Oct 19, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.46
Upside: -
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $7.08
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $32.95
Upside: +15.33%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $22.98
Upside: -